The beginnings of the thinking brain

Oxford researchers have identified the very first neurons in the human cerebral cortex, the part of the brain that sets us apart from all other animals.

Dr Irina Bystron and colleagues from the Department of Physiology, Anatomy and Genetics at the University of Oxford, together with Professor Pasko Rakic, a leading neuroscientist at Yale University, describe for the first time in Nature Neuroscience the very earliest nerve cells in the part of the developing human brain that becomes the cerebral cortex.

The cerebral cortex is largely responsible for human cognition, playing an essential role in perception, memory, thought, language, mental ability, intellect and consciousness. It is also responsible for our voluntary actions. As adults our cerebral cortex accounts for 40 per cent of the brain’s weight and is composed of about 20 billion neurons. The new findings show that its first neurons are in place much earlier than previously thought – approximately 31 days after fertilization, when the entire embryo is only about 4 mm long and shaped a bit like a comma, before the development of arms, legs or eyes.

The team used cutting-edge techniques, including technologies that allowed them to study which genes are turned on in individual cells. These methods enabled them to identify the first neurons, which they call ‘predecessor’ cells.

Predecessor cells are unusual in many respects. Unlike normal nerve cells, they do not have fibres connecting to other neurons. They do, however, have very long thick processes, or ‘tails’, one stretching out in front of the cell body, the other trailing behind. Analysis of the skeleton of these cells suggests that they move upwards in the surface of the developing brain and enter the future cortex. Their processes form a vast network, and the researchers speculate that this web of processes might be used to guide the migration and development of later cells. Professor Colin Blakemore, one of the authors on the paper, said: ‘We suspect that these early cells have a special role in development, setting the scene for and controlling neurons that are generated later, and dying when their job is done.’

Unravelling the early development of the cerebral cortex may help in understanding the many developmental disorders of higher brain function, such as autism, schizophrenia, childhood epilepsy, developmental dyslexia and mental retardation.

It might also provide the key to a question that has puzzled evolutionary biologists, namely how the cerebral hemispheres of our hominid ancestors expanded massively, starting about five million years ago. Despite only a 1 per cent genetic difference between humans and gorillas, the human cerebral cortex is four times larger, and our ability to think, understand and to develop culture is dramatically different. It is possible that understanding the way the cerebral cortex develops, and how its development differs from that of other animals, might help explain what happened to give us such clever brains. The researchers are particularly interested in the fact that predecessor cells have never been described in other animals. ‘A re-examination of early brain development in other species is urgently needed to determine whether predecessor cells are really unique to the human brain,’ said Dr Bystron.

Source: University of Oxford

Related stories:

Chandelier cells unveil human cognition
What is it that distinguishes humans from other mammals? The answer to this question lies in the neocortex – the part of the brain responsible for sensory perceptions, conscious thought, and language. Humans have a considerably larger neocortex than other mammals, making it an ideal subject for the research of higher cognition. In this month's issue of PLoS Biology, authors Tamas, et al, reveal new insights into the mysteries of neocortex organization and function.
Researchers piece together gene 'network' linked to schizophrenia
Reporting this week in the Archives of General Psychiatry, researchers at the Johns Hopkins University School of Medicine have uncovered for the first time molecular circuitry associated with schizophrenia that links three previously known, yet unrelated proteins.
Animal study suggests inadequate sleep may exacerbate cellular aging in the elderly
Researchers at the University of Pennsylvania School of Medicine have shown that the unfolded protein response, which is a reaction to stress induced by sleep deprivation, is impaired in the brains of old mice.
Study identifies toxic key to Alzheimer’s disease memory loss
Using new scientific techniques, scientists have unlocked the cascade of molecular events that lead to Alzheimer’s disease. The scientific findings published in the latest edition of Nature Medicine suggest a potential new target for the development of drug therapies to fight the irreversible and degenerative disease which affects some 29.8 million people worldwide. The total worldwide societal cost of dementia was estimated at somewhere in the region of US$315.4 billion in 2005.

Antidepressants enhance neuronal plasticity in the visual system
In the April 18 issue of Science, scientists from the Scuola Normale Superiore in Pisa, Italy and the Neuroscience Centre at the University of Helsinki, Finland, provide new information about the mechanism of action of antidepressant drugs. In addition, the study suggests that antidepressants could also be used for the treatment of amblyopia. However, to produce a functional effect, antidepressant treatment also seems to require environmental stimuli, such as rehabilitation or therapy.
Key factor in brain development revealed, offers insight into disorder
In the earliest days of brain development, the brain’s first cells – neuroepithelial stem cells -- divide continuously, producing a population of cells that eventually evolves into the various cells of the fully formed brain. Now, scientists have identified a gene that, in mice, is critical for these stem cells to divide correctly. Without it, they fail to divide, and die.
Promising new drug targets identified for Huntington's disease
Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease. Scientists at the University of Cambridge have identified a number of candidate drugs to investigate further which encourage cells to "eat" the malformed proteins that lead to the disease.
Post brain injury: New nerve cells originate from neural stem cells
Most cells in the human brain are not nerve cells, but supporting cells (glial cells). They serve as a framework for nerve cells and play an important role in the wound reaction that occurs with injuries to the brain. However, what these ‘reactive glial cells’ in the brains of mice and men originate from, and which cells they evolve into was hitherto unknown.

News discussion:

Medicine & Health news